The research is being carried out by Cats Protection, RSPCA, PDSA, Wood Green The Animal Charity, Blue Cross, Celia Hammond Animal Trust, Battersea, The Mayhew Animal Home, SSPCA and International Cat Care, with support from Bristol University.
The study involves four short (<15 minute) questionnaires spread over a 6-month period, for which you could also win a £50 voucher.
Click here to find out more and sign up www.surveymonkey.co.uk/r/neutering
The new products are:
Leon Wright, Managing Director, said: "At Vet Direct, we’re always looking for ways to improve our service – making small changes which will have a big impact on the levels of care our clients can provide.
"We know that vets, veterinary nurses and practice managers don’t always have the time to try out new products before purchasing, and that’s why our dedicated team of sales staff test every item before adding them to our catalogue - ensuring that we only stock the highest quality products."
For more information on any of the new products, visit www.vet-direct.com or call 0800 068 3300.
The company says the new addition leverages a combination of image recognition technology, algorithms, and cloud-based deep learning AI to enable accurate, in-clinic sediment analysis of fresh urine, delivering results within minutes.
The system evaluates red and white blood cells, squamous and other epithelial cells (e.g. urothelial and renal tubular epithelial cells), hyaline and non-hyaline casts, struvite and calcium oxalate dihydrate crystals, and cocci and rod bacteria.
Zoetis says its performance is comparable to that of a clinical pathologist.
Richard Goldstein, DVM, DACVIM, DECVIM-CA, Vice President and Chief Medical Officer, Global Diagnostics Medical Affairs at Zoetis said: “Urinalysis is an essential diagnostic test for veterinary surgeons, and often a good indicator of potential wider issues.
"Having the ability to get these results faster will improve the speed and level of care teams can provide their patients, facilitating efficient medical decision-making and helping to ensure smooth workflows.
The first, which covers three topics: canine uveitis, canine glaucoma and non-healing corneal ulcer, is for the entire practice. It normally costs £95 per practice, but for VetSurgeon.org members, it's £70.
To book, visit: https://docs.google.com/forms/d/e/1FAIpQLScSSbUDCcC53cvPJtj1oPkJFEoDjJ3Tdij_y9iFtr7emBvkoQ/viewform?usp=pp_url
The second course is 'Ophthalmic Examination in the Dogs and Cats', which costs £25 for VetSurgeon.org members, that is reduced to £15 per person.
To book, visit: https://docs.google.com/forms/d/e/1FAIpQLSfnBizM5NmFGwWeDqtdXy9zCq8KdFgGI2e5D8pjuWOTuPln0Q/viewform?usp=pp_url
Originally from Belgium, Tamir, who qualified at Glasgow in 2001, started Vision Vet in 2009 and gained his National French Certificate in Ophthalmology (broadly equivalent to the UK Cert) in 2011.
https://www.vision-vet.co.uk
Dechra says the ability to split Prednicortone into 1.25 mg doses is particularly useful when used alongside Zycortal, the only licensed treatment for canine Addison’s disease in Europe.
Dechra Brand Manager Carol Morgan said: "Dogs with primary Addison’s disease have insufficient levels of natural mineralocorticoids (primarily aldosterone) and glucocorticoids (primarily cortisol). Zycortal contains DOCP, a synthetically produced steroid hormone, which acts in a similar way to aldosterone.
"It causes sodium retention and potassium excretion, helping to maintain water balance but Zycortal only replaces the mineralocorticoid. Therefore, a daily oral glucocorticoid treatment, such as Prednicortone, is needed to address the cortisol deficiency, alongside Zycortal.
"The amount of glucocorticoid administered should be adjusted to the individual dog’s need and it is likely that the dose required will be reduced over time."
She added that a combined approach of Zycortal and Prednicortone allowed independent dose titration of both mineralocorticoids and glucocorticoids.
"The advantage of prescribing the two treatments is that the dosage for each component can be tailored to an individual animal’s response. This leads to a reduction in the side effects usually associated with over-supplementation of glucocorticoids."
There are 250 tablets in a pack and Prednicortone offers accurate dosing using a double divisible SmartTab format and accurate dispensing via blister packs. The flavoured tablets also encourage easy oral administration.
For more information, visit www.dechra.co.uk.
What is 'quality improvement', you ask? Good question. Sure, it's an improvement in, er, quality. But of what?
'Quality improvement' is a term adopted from the human healthcare sector, variously defined as anything which makes: "healthcare safer, effective, patient-centred, timely, efficient and equitable (NHS)", or "the combined and unceasing efforts of everyone—healthcare professionals, patients and their families, researchers, payers, planners and educators—to make the changes that will lead to better patient outcomes (health), better system performance (care) and better professional development (BMJ)."
The RCVS research project, which is being conducted by RAND EUROPE, will assess current perceptions and adoption of quality improvement in the veterinary profession.
Specifically, it'll look at the drivers, barriers and expectations associated with QI, with the ultimate goal of strengthening the support provided to the profession.
Chris Gush, Executive Director of RCVS Knowledge, said: "We are delighted to be launching this research project with RAND Europe.
"We know that many of our colleagues across the profession have embedded quality improvement into their practice to great benefit, while we are also aware that it can be a challenge to do so all of the time.
"This research will provide an unprecedented body of evidence on the experiences and perceptions of QI, which will be critical to how we work to support the sector in this area going forward."
Integral to the research is a survey which all members of the profession are invited to take part in, here: bit.ly/QIvetsurvey.
The survey will be live for six weeks, closing early April. It takes around ten minutes to complete, with a prize of one £150 Amazon voucher on offer. Responses will be anonymised.
You can read more about Quality Improvement on the RCVS Knowledge website, here: https://knowledge.rcvs.org.uk/quality-improvement/
The BSAVA has announced the launch of its third smartphone app - the BSAVA Small Animal Formulary App.
This member-only access app is available to download now from iTunes and Android Market and offers the same reference materials found in the latest 7th edition printed version.
The BSAVA says the app contains more than 450 drug monographs and a wealth of additional information, allowing easy and rapid access to vital information about those medications that veterinary surgeons most commonly prescribe. It is hoped that the convenience of having the BSAVA Small Animal Formulary on a smartphone will mean that vets in practice will always have this valuable reference tool within easy reach.
Once the app is installed it will ask for a validation code that can be obtained from the smartphone app validation code page within My BSAVA pages at www.bsava.com. All future BSAVA member-only smartphone apps will be validated using the same process.
BSAVA IT Manager Emma Hayes said: "BSAVA is continually aiming to provide a range of valuable member benefits in a variety of formats so they can be used in the most efficient and effective way by our members. The BSAVA Formulary was a natural candidate for release as a mobile application, following the successful launch as an online searchable database at Congress in April. By developing this application it has also provided us with a platform that will enable us to produce additional useful applications in the future that can provide unrestricted content for our members."
The BSAVA Small Animal Formulary App follows on from the BSAVA Congress App and the BSAVA Guide to the use of Veterinary Medicines App. You can find out more about these other BSAVA smartphone apps through My BSAVA at www.bsava.com.
Petplan is giving away a VIP trip for two people to this year's 'Petplan Veterinary Awards' in Birmingham on 31st March.
The prize includes two admission tickets to the awards ceremony, as well as accommodation at a top hotel in Birmingham.
Veterinary staff can be in with a chance at winning this exclusive opportunity by nominating their practice or a member of staff for the following awards:
Alison Andrew, Petplan's Marketing Manager, said, "Veterinary professionals up and down the country show great commitment and dedication to our pets everyday and the awards are an opportunity to recognise all their hard work. By nominating a colleague you can not only show them your appreciation but you can also going into the draw to win a fantastic night out"
By making a nomination at www.petplan.co.uk/vetawards you'll automatically be entered into the draw to win the VIP tickets to the evening.
Nominations for the awards close on the 4th February and the winner of the VIP tickets will be announced in late February.
CEVA Animal Health's live enzootic abortion vaccine, CEVAC® Chlamydophila, has been renamed CEVAC® Chlamydia and repackaged in a larger bottle size.
According to the company, infectious abortion, particularly enzootic abortion (Chlamydiosis) can wipe out up to 50% of lambs but strategic use of CEVAC Chlamydia, a live enzootic abortion vaccine, can help keep the flock safe. It can prevent abortion and also control excretion and the threat of infection. For added convenience CEVAC Chlamydia can be used on the same day as the toxoplasmosis vaccine. This can save administration time and money.
For extra efficiency with big flocks CEVAC Chlamydia is now available in a larger, 50 dose bottle in addition to the original 20 dose bottle. It is administered using a special multi-dose injector gun.
CEVA says that a strategic vaccination every four years will help flocks remain chlamydiosis-free. Routine preventative measures are also advised prior to mating and when new sheep are introduced to the flock, to ensure abortion and infection rates always remain as low as possible. All animals should be vaccinated in the first year, with replacements being vaccinated from six months of age, at least four weeks prior to tupping.
For further product information contact your local CEVA representative or CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG or visit the website at www.ceva.uk.com
Over 25% of the 1001 veterinary professionals who responded felt that the use of technology for triage and or consultations had either improved efficiency or the service offered to clients.
More than 10% said the pandemic had led to practices taking actions which streamlined client processes such as taking payments and booking appointments online or by phone.
The survey results are included in a presentation at the BSAVA Virtual Congress: "Lessons from Lockdown:Telemedicine is here to stay", which forms part of the current topics stream on Saturday 27th March. Brian Faulkner will take a look at maintaining relationships and changing dynamics with remote consults, communication challenges and opportunities. Matt Flann will follow with: "A practical perspective – how we have used it, what have we learned?"
BSAVA President Professor Ian Ramsey said: “The survey results have given us an important insight on how technology is being deployed to help the profession continue to help pets and their owners safely and to the best of their ability in these difficult circumstances.
"Vets have embraced innovations in practice such as telephone triage, remote consultations and digital communications. These have shown us that, as within the human healthcare sector, we can continue to deliver our vital services, possibly to an even more efficient and effective standard, despite the restrictions.
"Our Congress session on lockdown learnings promises to make for compelling listening with important ramifications for veterinary practice even after the pandemic has receded to a bitter memory. As we return to degrees of normality these innovations should not be discarded, but equally must not be allowed to generate the inequalities that go hand in hand with them if some practices and owners are inadvertently left behind.”
To register for BSAVA Congress, visit https://www.bsavaevents.com/bsavacongress2021/en/page/home
Reference
Running throughout October, it is Ceva's third TV campaign this year to raise awareness of the benefits of Feliway and Adaptil amongst pet owners.
The campaign starts with a Feliway Classic advertisement running from 3rd October until 16th October, followed by an Adaptil advertisement until 30th October, timed for the run up to the firework season.
The new TV advertising campaign will target 18.5 million pet owners and it will air on all the C4 channels, including Channel 4, E4, More4, Film4, Drama, Good Food, Really, W and Home, with two spots during the popular Channel 4 TV show Great British Bake Off, which has 6.7 million viewers.
The TV advertising campaign will be supported by a Sky Adsmart and social media campaign for ADAPTIL.
Claire Russell, product manager for Feliway and Adaptil at Ceva Animal Health, said: "Our autumn Feliway and Adaptil TV advertising campaign is our biggest, most extensive campaign to date. It demonstrates our commitment to raising awareness of how anxiety in pets can affect the relationship with their owners and how Feliway and Adaptil can help."
For further information, visit www.feliway.com or www.adaptil.com.
Armed with the new microscope, New Forest Equine Vets (NFEV) has started offering a mobile equine veterinary service, including expert worming advice.
The microscope captures images with a resolution of 1 micron, with a live magnification of x200 and x400 or more, which means that the practice can carry out an accurate egg count in the yard, rather than sending faecal samples off to the lab.
This, they say, allows for a more a more accurate result, because posting faeces can lead to the sample desiccating and the eggs hatching, leading to false negative results. It also allows the veterinary surgeon to give immediate advice and treatment.
Dr. Beth Robinson BVSc Cert AVP(EP) MRCVS, co-owner of NFEV, says "One of the main aims of performing worm egg counts is to identify horses shedding low numbers of eggs so that we can maintain a low number of parasites on the pasture that have not been exposed to wormers and therefore have not been placed under selection pressure for resistance. In horses shedding high numbers of eggs, worm egg count reduction tests are a useful way of assessing whether treatment has been effective."
Andrew Monk, co-founder of ioLight, said: "The product is incredibly simple to use. By using a tablet both the owner and vet can view the image and discuss treatment. We hope that more horse owners in the New Forest will use the services from NFEV to protect their animals, and that it will encourage other equine practices to purchase a microscope so they can also offer a similar high quality service. We have made a video with NFEV to demonstrate their service and encourage other equine vets to use the ioLight microscope in their own mobile clinics."
Beth added: "We are delighted to be working with ioLight and horse owners to keep their animals healthy and improve equine welfare."
Consistent with previous surveys, lameness was shown to be more likely to be caused by conditions such as osteoarthritis in the limb rather than problems in the foot.
Blue Cross carries out NEHS in May each year in partnership with the British Equine Veterinary Association (BEVA). It is sponsored by Dodson & Horrell and Zoetis and supported by the UK’s leading equestrian organisations and charities.
This year saw a 14% increase in participation compared to 2015, with survey records returned for almost 16,751 horses, ponies, donkeys and mules and 5635 people taking part. Most horses were kept in livery or a private yard and used for leisure and hacking.
Lameness has been consistently seen as the most common syndrome affecting horses in the NEHS results year on year. In the latest survey a total of 32.9% (24.4% in 2015) of horses and ponies with health problems were recorded as lame. Overall, as in previous years, lameness in the limb was more common than lameness caused by problems in the foot.
A breakdown of the types of lameness revealed that 47.4% were recorded as suffering from proximal limb lameness, 31.9% from causes of foot lameness other than laminitis and 20.7% from laminitis. Degenerative joint disease (including foot and proximal limb) was the most frequently reported single cause of lameness (41.2% of all lameness) and the most frequently reported joint affected by DJD was the hock (15.3% of all lameness).
Reports of foot lameness (excluding laminitis) more than doubled this year at 10.5% (4.5% in 2015) of all syndromes reported with pus in the foot being the most frequently recorded problem. This could possibly be attributed to the persistent wet weather during and prior to the survey, which can increase susceptibility to the condition.
Josh Slater from the Royal Veterinary College, who is a member of BEVA’s Health & Medicines Committee and analysed the NEHS data, said: "The data gleaned from the survey remains consistent year on year, confirming the reliability of our findings for benchmarking, referencing and research. This year’s increase in overall lameness may be in part attributed to the higher incidence of pus in the foot but may also be because owners are becoming more aware of lameness issues. Ongoing research on lameness has generated significant media coverage over the past year, helping to raise understanding of the importance of accurate diagnosis and treatment both from welfare and performance perspectives."
The six most notable disease syndromes identified in the 2016 National Equine Health Survey are:
Gemma Taylor, Education Officer at Blue Cross said: "The significant increase in participation again this year shows that owners and keepers of horses are really getting behind the survey and recognising its importance in safeguarding the future health and of the UK’s horses. Over the past year NEHS data has been referred to in leading equestrian and veterinary media, showing its credibility as a valuable benchmarking reference."
The 2016 NEHS survey results are now available. To download a copy visit http://www.bluecross.org.uk/nehs2016results and to register for next year’s survey please visit www.bluecross.org.uk/nehs
The awards are to recognise the work carried out by veterinary professionals.
Last year Petplan had a remarkable 37,000 nominations, for the five award categories: Practice of the Year, Vet of the Year, Vet Nurse of the Year, Practice Manager of the Year and Practice Support Staff of the Year.
James Barnes, head of sales & partnerships at Petplan, said: “For over two decades we’ve been recognising the brilliant work of the UK’s veterinary professionals. Every year the quality of entries is incredibly high but we know that during 2020 the profession really went the extra mile to take care of the nation’s pets so we expect the 2021 awards to be extra special.
To nominate a colleague or your practice, visit: https://www.petplanvet.co.uk/veterinary-practice-insurance/veterinary-awards before nominations close on 18th January 2021.
Over 90% of the 156 respondents (predominantly vets, but also managers) believed CT was important in first opinion practice, but nearly half did not have access to a scanner.
25% said they were interested in buying a CT scanner, mainly for the improved diagnostics and desire to keep more cases in-house.
The main reasons for not buying a CT scanner were: space, cost and lack of confidence.
Matt Winter, radiologist and CVMO at VetCT said: “Imaging in first opinion practice is evolving rapidly with innovations in veterinary-specific CT technology, modern machines are more available and affordable than ever.
"We need to build confidence through training and understanding of the technology, and the comprehensive support available to practices.”
While practices with a CT scanner felt they were using it optimally for the most part, specialist radiologist reporting emerged as the most significant factor towards optimising its use.
However, a third of respondents not currently using teleradiology (the remote reporting by specialist radiologists of diagnostic images acquired by a practice), said they did not know enough about it and/or hadn’t considered it.
Matt said: “Expert teleradiology to support with image interpretation is enabling more practices than ever to offer advanced imaging and provide state-of-the-art diagnostics for patients, meeting growing client expectations, elevating patient care and improving outcomes."
VetCT’s webinars on CT optimisation are available on Youtube: https://www.youtube.com/c/Vetctspecialists
Some 150 practices currently use Vidivet, which was set up by Ben Sweeney MRCVS (pictured) in 2020.
He said: “I started VidiVet as I wanted people to be able to access high quality, impartial care for their pets that allows them to make more informed decisions around their treatment with expert information, rather than resorting to the internet.
"As a vet I also wanted to make life easier for those working within veterinary practices.
"VidiVet relieves part of the burden veterinary practices face by offering a trusted digital triage service for their clients.
"Our digital service can provide a helpful extension to a practice which dramatically reduces admin and saves time for the in-house team.
"Crucially, we offer peace of mind and reduce anxiety for pet owners, and with over 96% of VidiVet out of hours calls redirected to the pet owner’s registered vet, it can really enhance the practice bond by using digital care to augment physical care."
Before the Provet partnership, OOH case notes were sent to client practices which then had to enter them onto their systems manually.
Vidivet says the intregration with Provet means less admin and time savings for practices and a quicker follow up for pet owners.
https://vidivet.com
https://www.provet.cloud
At the hearing, the Disciplinary Committee considered whether she had accepted the findings of the Committee at the original inquiry hearing, the seriousness of those findings, whether she had demonstrated insight into her past conduct, and the protection of the public and the public interest.
In her restoration application, Dr Burrows included continuing professional development (CPD) certificates for the courses she had completed since her removal from the Register, letters/informal witness statements from the veterinary surgeons and nurses she had worked who had expressed a willingness to employ her again, together with character references and reflection statements.
She also made a detailed opening statement in support of her application, in which she said that the period since her name was removed from the Register was extremely difficult and also that she now unconditionally accepted all the Committee’s original findings in May 2021, some of which she had previously denied and had failed to acknowledge.
Dr Burrows went on to state that she only had herself to blame for her actions and that she now understood and accepted that the original sanction of removal from the register had needed to be severe given the serious breach of trust to the public, to the veterinary profession and the insurance industry that was a direct consequence of her dishonest actions.
Since removal from the Register, Dr Burrows had taken on the role of receptionist in a Vets4Pets practice in Cardiff, which required her to deal directly with the public and their insurance requests and entitlements.
She stated that as a result of her involvement over the past 18 months in processing insurance claims, she acknowledges the “delicate” relationship between veterinary surgeons, clients and insurers.
Additionally, working as a receptionist, had allowed her to recognise the need for contemporaneous and clear clinical notes.
She also highlighted her CPD, which was relevant to insurance, as well as the fact she’d undertaken a professional ethics course to assist her rehabilitation, reflection, and insight.
In support of Dr Burrows’ restoration to the Register, the Committee took into account three witness accounts from people who work at the Vets4Pets branch where Dr Burrows works as a receptionist.
All witnesses gave positive reflections on Dr Burrows’ character and assured the Committee that they would provide the correct level of support to allow her to return to work safely and that they would have all the necessary safeguarding measures in place to ensure that the public’s and the profession’s interest is always at the forefront.
Judith Way, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee was impressed by the fact that busy professionals chose to give up their time to provide witness statements and give evidence in support of Dr Burrows’ application.
"All witnesses were clearly supportive of Dr Burrows’ request for restoration to the Register.
“The Committee found Dr Burrows to show remorse and she does now accept the findings of dishonesty that were made against her in the original enquiry hearing and stated that her conduct was dishonest.
"In the Committee’s view, the evidence given by Dr Burrows on affirmation was very believable and she now accepts her dishonesty together with the gravity of her dishonesty.
“The Committee also formed the view that the steps she has taken to address her dishonesty serve to confirm that she is passionate about the prospect that she be allowed to return to practise.
"The Committee was impressed by Dr Burrows and the evidence given and is now satisfied that she will ensure the highest standards of probity and honesty in the future.
“Having taken all evidence into account, the Committee is satisfied that the future welfare of animals under Dr Burrows’ responsibility will be properly protected, and that her future dealings with insurers will be honest in all respects and that the interests of the public will be met.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
The study “Hypoadrenocorticism in dogs under UK primary veterinary care: frequency, clinical approaches and risk factors1”, identified dogs diagnosed with hypoadrenocorticism from the electronic patient records of practices participating in the UK VetCompass programme during 2016.
The study aimed to estimate the frequency of hypoadrenocorticism in dogs under primary veterinary care in the UK, describe the diagnosis and clinical management of hypoadrenocorticism and report the risk factors for the disease.
Cases were categorised as having a laboratory-confirmed or presumed diagnosis, based on the information available in the electronic patient records. Multivariable logistic regression was used to identify demographic risk factors.
A total of 177 hypoadrenocorticism cases were identified from 905,543 dogs in 2016; 72 laboratory-confirmed and 105 presumed. The one-year period prevalence for hypoadrenocorticism in all dogs was 0.06%.
The most commonly recorded clinical signs included:
Imogen Schofield, corresponding author for the paper, said: “By presenting epidemiological data on dogs with hypoadrenocorticism attending primary-care practice, this study provides representative and relatable information for vets working in primary-care practice in the UK. It should be borne in mind that diagnostic and clinical management data were reported for laboratory-confirmed cases only.
“Breed, age, neuter status and insurance status were all associated with a laboratory-confirmed diagnosis of hypoadrenocorticism. The standard poodle had 51.38 times the odds of hypoadrenocorticism compared with crossbreeds. The labradoodle (OR: 7.40) and West Highland white terrier (OR: 5.84) also had increased odds.
Nicola Di Girolamo, Editor of JSAP, said: “This is the largest study to date to provide benchmark data on hypoadrenocorticism in dogs under primary veterinary care in the UK. Given that the frequency of hypoadrenocorticism has rarely been reported, it is typically difficult to diagnose due to the non-specific clinical signs associated with the disease, and many previous studies have focussed on referral populations. This is a welcome publication adding to the evidence base of an important topic.”
The full article can be found in the May issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13285. It is open access and can be freely accessed by anyone.
Practices will be able to offer customers increased support for their worming programmes in 2010, as part of a new initiative from Eqvalan® manufacturer, Merial.
Eqvalan product manager Claire Edmunds said: "The SMART worming campaign is designed to encourage owners to Simply Monitor, Assess Risk and, if necessary, Treat with the most appropriate wormer.
"We know that worming can be confusing for horse owners, so the SMART approach is designed to help them manage their worming programmes more easily, whilst also ensuring that wormers are used in a way that may help prevent the development of resistance.
Practices purchasing Eqvalan Duo during February and March can get 4 tubes free when they purchase 20. In addition, to kick start the SMART campaign for each order on the above offer, Merial will supply 20 free Worm Egg Count vouchers worth £10/€10 each. For those practices with their own testing facilities, the company is also offering promotional support to help encourage increased uptake and client buy-in.
Claire added: "As well as continuing with the successful free worm egg count campaign available for practices during February and March, owners will also have access to a personalised on-line planner, as well as text and email alerts.
"The campaign is being supported with new point of sale material and a prominent consumer advertising campaign. In addition we also have an extensive VN SQP CPD training programme planned for 2010.
"With the consensus of expert opinion on the future of worming firmly behind the use of targeted programmes incorporating worm egg counts, there has never been a more important time to get closer to clients and help them with their worming strategies."
If you would like further information, please contact your local territory manager or call the Merial Customer Support Centre on 0845 601 4236.
Dechra Veterinary Products has introduced two additional new products to its Veterinary Essentials range: Alvegesic vet and Clavudale.
Alvegesic vet contains butorphanol, a well-known and widely used drug for sedation, anaesthesia and analgesia in both dogs and cats. In horses, Alvegesic vet is indicated for analgesia and sedation.
Alvegesic vet is available in 10ml multidose vials and is licensed for administration by intravenous, intramuscular or subcutaneous routes, depending on indication, in both cats and dogs.
The other new addition to the Veterinary Essentials range is Clavudale, which contains the broad spectrum antibiotic amoxicillin, potentiated with clavulanic acid. Clavudale is bactericidal, active against a wide variety of bacterial organisms, including gram-positives and gram-negatives.
Clavudale is effective in treating a wide range of bacterial diseases of cats and dogs. These include: skin disease; soft tissue infections; dental infections; urinary tract infections; respiratory disease and enteritis. Clavudale is supplied in boxes of 24 tablets, with 4 blister strips of six tablets.
Further information on Alvegesic vet and Clavudale is available by calling Liz Rawlings at Dechra on 01743 441 632 or visiting www.dechra.com
"The majority of veterinary medicines used in the UK (and ingredients and components to make them) are either produced in or enter via the EU. The government is working with animal health companies who have been carrying out extensive contingency planning for all EU Exit scenarios, including no deal. These plans cover all aspects of their supply chains, from regulatory compliance and stocking levels to logistics and customs. They also include, as appropriate, increasing stocks of products in the UK, changing supply routes, transferring marketing authorisations and other regulatory processes.
"To reduce any risk to medicines availability in the UK, detailed planning is ongoing to ensure that supply chain measures are appropriate to address the sector’s complex needs and priorities.
"Much work has been done by companies with the objective of ensuring fair and appropriate distribution of this inventory to avoid disruption.
"Supply is expected to cope with a normal ordering pattern with adequate forward planning and communication with suppliers.
"With this planning in place, we are confident that we have made every effort to ensure continuity of supply of veterinary medicines in the UK."
Well that makes a nice change from the incessantly and determinedly gloomy picture painted elsewhere.
The company says Bovela is the only BVD vaccine available proven to provide 12 months’ protection, against both types of BVD, and after only one shot.
Cattle business manager, Robert Bakewell said: "Provided Bovela is used as recommended on the product label, we are happy to guarantee that it will prevent the birth of PI (persistently infected) calves caused by transplacental infection by the BVD virus.
"We are also encouraging farmers to seek advice and input from their vet about BVD control by offering a £50 voucher towards testing for Bovela users. All herd owners need to do is speak to their veterinary surgeon or email bvdzero.uk@boehringer.com."
In the BVA/AVS Survey 2012, sponsored by Vets4Pets, 82% of students reported suffering from stress currently or while at university, with this figure falling to 63% of students in 2016. Those who reported suffering from depression also fell from 33% to 27%.
By far the biggest contributor to, or trigger of, mental health problems was veterinary students’ studies, with 83% citing this as the main reason. Other contributions to, or triggers of, mental health issues cited by students included:
Researchers say that the fall in students reporting stress could be attributed to improved university support for students, with almost three quarters (72%) of survey respondents saying they felt supported in terms of welfare.
In recent years, a number of initiatives have been developed to help and support students. They range from the counselling and peer mentoring services available through individual universities to the confidential support offered by the independent charity Vetlife through its helpline, health support programme and fund for financial support.
While the significant fall in veterinary students reporting stress is positive, the BVA/AVS survey also shows that there are a range of factors that affect students, including financial pressures. A third of veterinary students work part-time to supplement their income and around half of students say they usually have less funds than they need, with the average shortfall per term estimated at £1,231.
Hannah Mason, President of the Association of Veterinary Students, said: "There is no escaping that veterinary medicine is a challenging degree. On top of strenuous exams, holidays are filled with compulsory EMS making it hard to sustain part-time work which is often needed to supplement the expense of a five or six year degree. It is therefore no surprise that stress is a problem in the vet student population. Whilst it is pleasing to see that the numbers reporting stress have declined, the majority of vet students still report having suffered at some point during their degree. We now have various counselling services and peer support systems across the universities to help students to cope better. However, while it is important to have reactive strategies in place, we also need to examine the fundamental reasons why vet students are stressed and how we can prevent it from occurring."
Gudrun Ravetz, President of the British Veterinary Association, said: "A significant drop in those students reporting stress is very much to be welcomed. But any veterinary student feeling stressed, under pressure and unable to cope is one too many. The truth is that there will be pressure in the work we do and there will be times that we feel stressed. Veterinary medicine university courses are tough and that is reflected in studies being the number one contributor to mental health and wellbeing concerns in the survey. But as a veterinary family, we need to help our colleagues to cope from the earliest stages of their career and make the right resources available to them, along with creating the right kind of supportive culture. We also need to recognise and work on solutions for what can be a toxic mixture of a highly demanding course, little leisure time and huge financial pressure. It is the responsibility of everyone in the profession to nurture a robust, skilled, compassionate and happy new generation of vets."
The survey is open to all veterinary surgeon members and participants will be entered into a free prize draw to win £500 of BEVA CPD vouchers.
As we all know, antibiotic resistance is increasing throughout human and veterinary medicine, and there are few new antibiotics being produced. As BEVA says, it’s therefore imperative for vets to protect the usage of antimicrobials to maintain their effectiveness for the future.
To that end, the purpose of the survey is to help fill in gaps in knowledge about how antimicrobials are being used and also the current landscape of resistant infections encountered in equine practice.
The survey has been designed by Amie Wilson and Dr Gina Pinchbeck at the University of Liverpool and Tim Mair the incoming President of BEVA.
Tim said: "This survey will assess any changes in prescribing of antimicrobials in equine practice since the last survey in 2009. In addition, we will collect data on the current frequency and types of antimicrobial resistant infections seen by clinicians in all areas of equine practice and what infection control and audit practices are currently using to combat this."
The survey results should lead to a greater understanding of the role of antimicrobial treatment in the overall epidemiology of antimicrobial resistance in horses and will help protect antibiotics for the future of equine and human health.
To take part in the survey, visit: https://liverpool.onlinesurveys.ac.uk/beva-questionnaire-2019-final
The results will be announced to coincide with European Antibiotic Awareness Day on 18 November 2019.
If you have any questions about the survey you can contact the researchers direct: Amie Wilson, University of Liverpool A.wilson3@liv.ac.uk; Dr Gina Pinchbeck, University of Liverpool ginap@liv.ac.uk; Tim Mair, British Equine Veterinary Association tim.mair@btinternet.com
Ceva Animal Health has launched Cardio Academy. The company says it's the first international cardiology e-learning programme offering CPD from leading international specialists.
The programme can be accessed at www.cardioacademy.cevalearn.com. It consists of a series of impressively well-produced interactive multimedia presentations lasting around 30 minutes, at the end of which you can download a CPD certificate.
The first two sessions, which are now available online, cover the Pathophysiology of Mitral Valve Disease, by Adrian Boswood, and Clinical Examination of the Cardiac Dog, by Gérard Le Bobinnec.
Product manager, Fraser Broadfoot MRCVS, said: "There have been many advances in the diagnosis and treatment of heart failure in recent years. The aim of this website is to become a practical and up-to-date resource on the management of heart failure in practice."